The global pharmaceutical market size is projected to increase from USD 1.74 billion in 2025 to USD 3.21 billion by 2035, with CAGR growth above 6.3%. Notable companies driving the industry include Merck & Co, Novo Nordisk, Pfizer, Eli Lilly, AbbVie, playing a pivotal role in market growth.

This statistic depicts the top ten pharmaceutical companies worldwide based on the global anti-diabetic revenue market share in 2017 and a projection for 2024. In 2017, Merck & Co accounted for some 12.8 percent of the global market for anti-diabetics, and is expected to decrease to some 5.3 percent in 2024. Anti-diabetic medication is commonly ingested orally, with the exception of insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are often called oral hypoglycemic agents or oral antihyperglycemic agents.